Search

Blog

Access to cannabis-based medicine applauded

MEMBER for Northern Tablelands Adam Marshall has welcomed the State Government’s regulatory changes which will now allow doctors in NSW to be able to apply to prescribe a broader range of cannabis-based medicines.

Mr Marshall said the move meant that cannabis-based medicines previously only able to be used in clinical trials in NSW could now be considered by doctors for patients who have exhausted standard treatment options.

“I strongly supported the medical cannabis trial when it first commenced, to have it available as a form of pain relief for people and young children who are seriously ill,” he said.

“This change increases the options available for doctors as it means a broader range of cannabis-based medicines can be prescribed – while the evidence-based research looking further into the role medicinal cannabis can play is continued.medicalcannabisthumb

“I’m delighted to see further progress being made on this issue – one close to the heart of many people in this region.”

Mr Marshall said patients wishing to investigate the use of cannabis-based medicines will need to talk with their doctor about suitability.

“There is still a lot to learn about safety and efficacy for different patient conditions and groups which is why the government is investing $21 million to further world leading evidence-based research into the safe and effective use of cannabis-based medicines,” he said.

The regulatory changes take effect from today.

Applications from prescribing doctors will be assessed by the Commonwealth Therapeutic Goods Administration and by a committee of medical experts on behalf of NSW Health.

For further information about the State Government’s medicinal cannabis initiatives, visit the website www.health.nsw.gov.au/cannabis or call 1800 217 257.

Click to read factsheet: Cannabis-based medicine factsheet

Regulatory changes in NSW will allow doctors to apply for prescriptions of a broader range of cannabis-based medicines.

The changes to the regulations surrounding cannabis-based medicines come as the NSW government invests $21 million to further evidence-based research into their safe and effective use.

NSW Premier Mike Baird has endorsed the move, as the new medicines can now be considered by doctors for patients who have exhausted standard treatment options.

“People who are seriously ill should be able to access these medicines if they are the most appropriate next step in their treatment,” Mr Baird said.

“This change increases the options available for doctors as it means a broader range of cannabis-based medicines can be prescribed – while we continue our evidence-based research looking further into the role medicinal cannabis can play.”

Applications from prescribing doctors will be assessed by the Commonwealth Therapeutic Goods Administration and by a committee of medical experts on behalf of NSW Health. Minister for Medical Research Pru Goward stressed the importance of evidence-based research into the safe and effective use of cannabis-based medicines, saying that NSW was regulating these medicines in the same way as any other emerging medicine.

For further information about the NSW Government’s medicinal cannabis initiatives visit NSW Health or call 1800 217 257.